Gujarat Themis Biosyn Ltd 506879.BO
₹400.50 ₹17.60 (4.60%) 1D
Last Updated: Jun 22, 12:00 AM·BSE
Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
506879.BO Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: February 23, 2026
Report Source: 2026 3rd Quarter Report
Gujarat Themis Biosyn Ltd. Stock Analysis 506879.BO
India Health Care Small Cap Report: Gujarat Themis Biosyn Ltd. operates as a pharmaceutical company. The firm is focused on the business of manufacturing and sale of finished active pharmaceutical ingredients (API) products by fermentation process. The firm operates through pharmaceuticals segment. Its product portfolio comprises Rifamycin-S and Lovastatin. The firm is manufacturing Rifamycin S, which is an intermediate for manufacturing the drug Rifampicin (an Antibiotic used for the treatment of several types of bacterial infections, including tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease.) and Rifamycin O, which is an intermediate for manufacturing the drug Rifaximin (this is an Antibiotic used for treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy).
Read More Gujarat Themis Biosyn Ltd (506879.BO) Chart
Key Statistics of Gujarat Themis Biosyn Ltd (506879.BO)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
₹382.90Volume
17.47KP/E Ratio (TTM)
88.2252 Week Range
Market Cap
38.89BAvg. Volume
23.41KDividend Yield
0.18%Financial Metrics & Statements of Gujarat Themis Biosyn Ltd (506879.BO)
FAQ's for Gujarat Themis Biosyn Ltd (506879.BO)
- According to Musaffa’s Shariah screening methodology, Gujarat Themis Biosyn Ltd (506879.BO) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Gujarat Themis Biosyn Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Gujarat Themis Biosyn Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Gujarat Themis Biosyn Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Gujarat Themis Biosyn Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Gujarat Themis Biosyn Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.